TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).
Recordati has executed transactions involving the sale of treasury shares to beneficiaries of its stock option plans. These transactions, carried out in November 2025, were completed at the exercise prices set when the options were initially granted, reflecting the company’s ongoing commitment to its stock option program.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR55.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica SPA is a pharmaceutical company based in Milan, Italy. It specializes in the development, production, and marketing of pharmaceuticals, focusing on treatments for rare diseases and specialty pharmaceuticals.
Average Trading Volume: 244,148
Technical Sentiment Signal: Buy
Current Market Cap: €10.22B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.